tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACET Stock Latest News

Adicet Bio’s Promising Pipeline and Strategic Focus Drive Buy Rating
RatingsAdicet Bio’s Promising Pipeline and Strategic Focus Drive Buy Rating
9h ago
ACET
Adicet Bio price target raised to $9 from $4 at H.C. Wainwright
PremiumThe Fly
Adicet Bio price target raised to $9 from $4 at H.C. Wainwright
5d ago
ACET
Adicet Bio Inc. Reports Q3 2025 Financial Results
PremiumCompany Announcements
Adicet Bio Inc. Reports Q3 2025 Financial Results
6d ago
ACET
Adicet Bio reports Q3 EPS , consensus (32c)
PremiumThe Fly
Adicet Bio reports Q3 EPS , consensus (32c)
6d ago
ACET
Adicet Bio reports Q3 EPS (29c), consensus (32c)
PremiumThe Fly
Adicet Bio reports Q3 EPS (29c), consensus (32c)
6d ago
ACET
Adicet Bio doses first patient in ADI-001 trial
PremiumThe FlyAdicet Bio doses first patient in ADI-001 trial
27d ago
ACET
Adicet Bio’s Promising Off-the-Shelf Cell Therapy Garners Buy Rating Due to Positive Clinical Outcomes and Strong Market Position
Premium
Ratings
Adicet Bio’s Promising Off-the-Shelf Cell Therapy Garners Buy Rating Due to Positive Clinical Outcomes and Strong Market Position
1M ago
ACET
Adicet Bio price target raised to $8 from $7 at Guggenheim
Premium
The Fly
Adicet Bio price target raised to $8 from $7 at Guggenheim
1M ago
ACET
Adicet Bio Receives Nasdaq Extension for Compliance
PremiumCompany Announcements
Adicet Bio Receives Nasdaq Extension for Compliance
1M ago
8K
ACET
Adicet Bio announces $80M registered direct offering
PremiumThe Fly
Adicet Bio announces $80M registered direct offering
1M ago
ACET
Adicet Bio Announces Major Stock Offering Agreement
PremiumCompany Announcements
Adicet Bio Announces Major Stock Offering Agreement
1M ago
8K
ACET
Adicet Bio Reports Promising Phase 1 Study Results
PremiumCompany Announcements
Adicet Bio Reports Promising Phase 1 Study Results
1M ago
8K
ACET
Adicet Bio’s ADI-001 shows positive preliminary Phase 1 results in LN and SLE
PremiumThe FlyAdicet Bio’s ADI-001 shows positive preliminary Phase 1 results in LN and SLE
1M ago
ACET
Adicet Bio’s Promising CAR γδ T Cell Therapy: A Buy Rating Amidst Anticipated Breakthroughs in Lupus Treatment
Premium
Ratings
Adicet Bio’s Promising CAR γδ T Cell Therapy: A Buy Rating Amidst Anticipated Breakthroughs in Lupus Treatment
1M ago
ACET
Adicet Bio’s Promising Developments and Strategic Advancements Justify Buy Rating
Premium
Ratings
Adicet Bio’s Promising Developments and Strategic Advancements Justify Buy Rating
3M ago
ACET
Adicet Bio: Strategic Advancements and Financial Prudence Drive Buy Rating
PremiumRatings
Adicet Bio: Strategic Advancements and Financial Prudence Drive Buy Rating
3M ago
ACET
Adicet Bio Reports Q2 2025 Financial Results
PremiumCompany Announcements
Adicet Bio Reports Q2 2025 Financial Results
3M ago
ACET
Adicet Bio reports Q2 EPS (34c), consensus (30c)
PremiumThe Fly
Adicet Bio reports Q2 EPS (34c), consensus (30c)
3M ago
ACET
Promising Pipeline and FDA Fast Track Designations Justify Buy Rating for Adicet Bio
PremiumRatings
Promising Pipeline and FDA Fast Track Designations Justify Buy Rating for Adicet Bio
4M ago
ACET
Adicet Bio doses first patient in second cohort of ADI-001 trial
PremiumThe FlyAdicet Bio doses first patient in second cohort of ADI-001 trial
4M ago
ACET
Adicet Bio Announces 30% Workforce Reduction Strategy
Premium
Company Announcements
Adicet Bio Announces 30% Workforce Reduction Strategy
4M ago
8K
ACET
Adicet Bio assumed with a Buy at H.C. Wainwright
Premium
The Fly
Adicet Bio assumed with a Buy at H.C. Wainwright
4M ago
ACET

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >